A 55-year-old male was admitted to our hospital for anemia and idiopathic fever. The patient complained of an intermittent fever and fatigue which had persisted for 3 weeks. Upon physical examination, he evidenced pallor and multiple lymph node enlargement of approximately 1 or 2 cm in both the cervical and inguinal areas. The patient’s complete blood count was abnormal, with hemoglobin 7.5 g/dL, a white blood count (WBC) of 4.84×10
9/l, and 257×10
9/l platelets. Lactate dehydrogenase (LDH) was increased (555 IU/l, normal 218-472 IU/l). The results of positron emission tomography/computed tomography (PET/CT) indicated strong 18F-fluorodeoxyglucose (18F-FDG) uptake at the nasopharynx, oropharynx, spleen, bone marrow, and multiple lymph node areas in the cervical, axillary, mediastinal, abdominal, retroperitoneal and inguinal sites, bilaterally. Under the suspicion of lymphoma, a lymph node biopsy was conducted on the cervical and inguinal areas, which revealed polymorphous neoplastic lymphoid cells with atypical nuclei (
Fig. 1). Immunohistochemical stains of the lymph node biopsy evidenced the following tumor-cell immunophenotypes: CD45RO+, EMA+, CD30+, CD3+, CD15-, CD10-, CD1a-, CD56-, CD20- and ALK-. Bone marrow aspiration was conducted by dry tap. The bone marrow examination revealed marked reticulin fibrosis, dysplastic megakaryocytic hyperplasia, and the suppression of normal hematopoiesis (
Fig. 2A-
C). Based on these findings, we diagnosed the patient as having ALCL of ALK negative with myelofibrosis. After 2 weeks of hospitalization, cytopenia (WBC 1.08×10
9/l, hemoglobin 8.0 g/dL, platelets 2×10
9/l) progressed rapidly, and chemotherapy with CHOP was initiated. His lymphadenopathy and fever rapidly regressed and cytopenia was mildly improved. But, nineteen days after chemotherapy, lymph nodes were enlarged and fever was recurred. Immediately, he was treated with biweekly CHOP plus Etoposide (CHOEP) with the support of granulocyte colony-stimulating factors (G-CSF). Fortunately, following of the third cycle of dose-dense CHOEP,cytopenia was normalized and lymph nodes weren’t palpated. After the fifth cycle of CHOEP, PET/CT evidenced no hypermetabolic lesions and the bone marrow biopsy evidenced an absence of fibrosis with hypocellular hematopoietic tissue of 20~30% in cellularity (
Fig. 2D). Autologous stem cells were mobilized with cisplatin, cytarabine, and dexamethasone (DHAP) plus 5 mg/kg/day G-CSF, and 3.29×10
6 CD34+ cells/kg were collected. On October 23, 2006, the patient underwent autologous PBSCT after conditioning with intravenous busulfan (from days -8 to -5; 3.2mg/kg per day), etoposide (from days -5 to -4; 400 mg/m
2 per day) and cyclophosphamide (from days -3 to -2; 60 mg/kg per day). He received G-CSF from day +1 to +20 to accelerated granulocyte recovery. The absolute neutrophil count reached 0.5×10
9/l and the patient’s platelet count reached 50×10
9/l on days +20 and +25, respectively. The course of the transplantation was generally uneventful, with good engraftment, and the patient was sent home after four weeks of hospitalization. After 36 months of Autologous PBSCT, the patient remained in complete remission on PET-CT (
Fig. 3) and was alive as of October 2009, with no progression of the disease.